01 30JANSSEN PHARMS
01 308513202
01 30Y
01 30Y
01 302027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205879
Patent Use Code : U-2632
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205879
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205879
Patent Use Code : U-2441
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204042
Patent Use Code : U-493
Delist Requested :
Patent Use Description : TREATMENT OF TYPE 2 DI...
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 204353
Patent Use Code : U-2632
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205879
Patent Use Code : U-2632
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
Patent Expiration Date : 2027-12-03
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE
US Patent Number : 8513202
Drug Substance Claim : Y
Drug Product Claim : Y
Application Number : 205879
Patent Use Code : U-2632
Delist Requested :
Patent Use Description :
Patent Expiration Date : 2027-12-03
